{"nct_id":"NCT00673049","title":"Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer","status":"TERMINATED","status_verified_date":"2013-07","start_date":"2008-05","start_date_type":null,"primary_completion_date":"2011-03","primary_completion_date_type":"ACTUAL","completion_date":"2012-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}